Eloralintide is a synthetic peptide commercialized by Eli Lilly and Co, with a leading Phase II program in Obesity.

Mazisotine is a small molecule commercialized by Eli Lilly and Co, with a leading Phase II program in Diabetic Neuropathic Pain.

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have competed for decades. In recent years, these two healthcare leaders ...

Eli Lilly ( LLY 0.86%) is a screaming buy because it makes the most potent weight-loss drug that's on the market right now, ...

Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business ...

Indiana’s Governor Eric Holcomb says he’s reflecting on his time as Governor now that it’s about to come to an end next month ...

ORLANDO -- A considerable amount of variability exists in surgical management of ileosigmoid fistulas in Crohn's disease (CD) ...

A subgroup analysis showed that the benefit in high-risk patients was limited to those with tumors >2 cm, reported Nan Chen, MD, of the University of Chicago, at the San Antonio Breast Cancer ...

Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...

President-elect Donald Trump set two tables for a dinner party this month with his choice for Health and Human Services ...

The Ripley County Community Foundation has announced the recipient of the 2025 Lilly Endowment Community Scholarship for ...